Taher has nearly two decades of management experience in the semiconductor engineering, internet technology innovation in education and life sciences industry. Prior to founding Cellworks Group Inc., he held senior management positions in Cadence Design Systems, Inc., Get2Chip Inc., Vitalect Inc. and Synopsys Inc.. He serves on the Board of Cellworks Group Inc.

Taher is the co-author of the books "Logic Synthesis Using Synopsys" edition 1,2 (Kluwer publication) and "It's the Methodology, Stupid!" (ByteK publication). He has also written and presented many articles in technical publications and industry conferences worldwide.

Taher was an adjunct faculty in extension programs of University of California , Santa Cruz , University of California Irvine and California State University, Northridge teaching classroom and e-learning courses on ASIC synthesis based methodology and Design for Testability. He holds a B.S.(Honors) in Electronics from University of Bombay; M.S.(Distinction) in Computer Engineering from California State University, Northridge; MBA from National University in Singapore and MBA from University of California, Los Angeles.

Pradeep was most recently Vice President and General Manager of Synthesis Solutions at Cadence Design Systems, Inc (CDNS) following its very successful $120M acquisition of Get2Chip in 2003. Under Pradeep's leadership, Get2Chip's synthesis solution has been one of the most externally recognized and fastest growing products in Cadence's product line up.

Prior to founding Get2chip/Meropa, he was part of the executive team (focusing on new products) of TriQuest design automation which was acquired by Summit Designs (SMMT). Before joining Triquest, Pradeep co-founded CyberX, a company focused on development of highly integrated smart ethernet switches. Prior to this Pradeep worked in various technical roles at Synopsys Inc. (SNPS), where he was involved in roll-out of several new technologies. Pradeep started his career at LSI logic Inc (LSI). Pradeep has a MSEE and BSCS/EE. He has many technical publications to his credit in the EDA, DSP, Communication and Parallel Processing areas. Pradeep received the outstanding researcher award (Sigma Xi) for his masters thesis. He is a prolific entrepreneur and also an angel investor in the technology space and sits on the boards of a few private companies and non-profit organizations.

Shireen, a Cellworks co-founder is a member of the senior executive team. She manages Cellworks Research and Development groups and drives the disease platform developments. She has over 16 years experience in research aligned to pharmaceutical, diagnostics and professional education fields at UC Davis, Stanford, BioGenex and Institute of Bioinformatics & Applied Biotechnology (IBAB). She serves on the Board of Cellworks Research India Limited (CRIL).

Her past professional experience include elucidating signal transduction pathways involved in the neural activity-dependent regulation of metabolic gene expression in skeletal muscle, helped her to connect/understand the bridge from physiology to molecular biology; applied research in the area of Cystic Fibrosis; setting up and managing the framework for the Online Continued Medical Education (CME) program; histopathology and Systems Biology at the bio-chemical and pathway abstraction level of disease physiology networks. She holds a PhD in Neurobiology from University of California , Davis.

Dr. Anand Anandkumar serves as the Managing Director and Chairman of the BOD of the India operations of Cellworks, He is primarily responsible for building up the world wide Business Development and External Alliances footprint for Cellworks. In addition Anandkumar is driving the entry of Cellworks into Industrial Biotransformation and Green Chemistry.

Anandkumar received his MS and PhD in Biomedical & Electrical Engineering from George Washington University, Washington DC. He is a veteran of the Semiconductor Industry with more than 18 years of experience, specializing in Electronic Design Automation (EDA) Software products, IC design and in setting up and running global operations in Emerging markets India and China. Before joining Cellworks, Anandkumar was the founding Managing Director of the India operations of Magma Design Automation, where he was responsible for setting up and driving many aspects of the Operations including RD, Product Engineering, Business Development and links to Government/Academia. The India operation of Magma which Anandkumar founded in 2003 is Magma's largest subsidiary with roughly 25% of the worldwide headcount.

Before joining Cellworks in 2009 he was the Principal Research Scientist in AstraZeneca India, where he spent more than 2 decades working in Infectious diseases, with a focus on Malaria and MTB. His current interest is in anti-infective drug discovery and recombininat DNA technology and its application in Industrial Biotechnology. He has published widely and has over ten international patents.

Dr. Santanu, received his PhD from Calcutta University in Biophysics in 1981 and was trained as a molecular biologist during his post doctoral stint in Baylor College of Medicine USA and Karolinska Institute Sweden.